Logo

Two Japanese BLIS Licenses Mark Biotique s Entre Into Asia-Pacific Market

Sep 09, 2002

NEW YORK, Sept. 9 - Biotique Systems today said Fujisawa Pharmaceutical, Ono Pharmaceutical, and Metabolex have signed annual software licenses for its BLIS technology.

 

Two of the licenses also represents Biotique's entrée into the Asia-Pacific pharma market: Fujisawa and Ono are based in Japan.

 

Each of the three deals gives provides access to one of Biotique's local-integration systems, which is scaleable and can be linked to multiple-research sites.

 

Click here for more information.

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.